Medical AI Imaging Firm VoxelCloud Wins RMB 100 Mln Series A+
Vcbeat, 9/28/17
Medical artificial intelligence imaging company VoxelCloud completed RMB 100 mln in Series A+ funding today, led by Chinese internet and mobile services firm Tencent (0700.HK) and with participation from Sequoia Capital and United Capital. The funding will be used to further integrate AI medical products with hospital scenarios.
VoxelCloud was founded in Los Angeles in 2015, and has teams in Shanghai and Suzhou. The company primarily uses AI and cloud computing technology to mine medical imaging and clinical data to help doctors analyze and diagnose diseases.
VoxelCloud's three primary product lines - lung cancer diagnosis, ophthalmology exams, and coronary CT analysis - are currently used by more than 50 hospitals in China and overseas, explained founder Ding Xiaowei. Since its launch, VoxelCloud has helped doctors diagnose approximately 50,000 patients with chest diseases, 50,000 patients with heart disease, and 100,000 patients with eye diseases.
VoxelCloud primarily partners with three categories of institutions: medical institutions, large-scale medical centers, and national screening programs; platform-based service providers; and device manufacturers. VoxelCloud make its services and technologies available on third-party service provider platforms, allowing its products to be used and verified in more cases. For hardware makers, Including VoxelCloud's analysis algorithms increases the value of medical devices for more differentiated pricing.
VoxelCloud's augmented coronary CT analysis product has been approved by the USA's FDA and Europe's CE certification for market access.
VoxelCloud previously won USD 8-digit Series A funding from Sequoia Capital and United Capital in May.
Keywords: VoxelCloud online healthcare VC M&A Ding Xiaowei Internet funding Tencent cloud computing Series A Sequoia Capital 0700.HK artificial intelligence United Capital